Search Medical Condition
Please enter condition
Please choose location from dropdown

Hypertriglyceridemia Clinical Trials

A listing of Hypertriglyceridemia medical research trials actively recruiting patient volunteers. Search for closest city to find more detailed information on a research study in your area.

RESULTS

Found (49) clinical trials

A clinical research study is underway for those who have been diagnosed with Type 2 diabetes, have high Triglycerides, low HDL cholesterol “good cholesterol”, and are at risk for future cardiovascular events. The main goal of this study is to learn, if a potential new medication can help prevent heart ...

Phase

Don't wait, participate! A clinical trial for high triglycerides is now enrolling in Gurnee, Illinois. Play an active role in your health care and contact us to see if you qualify to participate.

Phase

Don't wait, participate! A clinical trial for people with type 2 diabetes, who also have high triglycerides and low, good cholesterol is now enrolling.  Play an active role in your health care and contact us to see if you qualify to participate in this study.

Phase

Don't wait, participate! A clinical trial for type 2 diabetes with high triglycerides is now enrolling. Play an active role in your health care and contact us to see if you qualify to participate in this study.

Phase

To determine the efficacy of CaPre 4 g daily, compared to placebo, in lowering fasting triglyceride (TG) levels in patients with fasting TG levels ≥500 mg/dL and ≤1500 mg/dL (≥5.7 mmol/L and ≤17.0 mmol/L) after 12 weeks of treatment.

Phase

The primary objective of the study is to determine whether pemafibrate administered twice daily will delay the time to first occurrence of any component of the clinical composite endpoint of: nonfatal Myocardial Infarction (MI) nonfatal ischemic stroke hospitalization for unstable angina requiring unplanned coronary revascularization; or Cardio Vascular (CV) death.

Phase N/A

The primary objective of the study is to determine whether pemafibrate administered twice daily will delay the time to first occurrence of any component of the clinical composite endpoint of: nonfatal Myocardial Infarction (MI) nonfatal ischemic stroke hospitalization for unstable angina requiring unplanned coronary revascularization; or Cardio Vascular (CV) death. ...

Phase N/A

Do you have hypertriglyceridemia? 

Phase

A Prospective Observational Program Using Digital Technology Tools to Enhance Patient Adherence to Omacor Therapy

It is known that only 50% of patients with chronic diseases adhere to medical recommendations; at the same time, high patient adherence significantly improve the survival of patients with chronic diseases. The treatment duration required to achieve a significant reduction in the risk of cardiovascular complications is the subject of ...

Phase N/A

Study of Gemcabene in Adults With FPLD

Patients with typical Familial Partial Lipodystrophy Disease (FPLD) have a marked loss of subcutaneous fat from the extremities and trunk accompanied by a variable amount of excess fat deposition in the nonlipodystrophic areas such as the face, chin, back, and intraabdominal regions. Dietary fat restriction and other lifestyle changes are ...

Phase